<DOC>
	<DOCNO>NCT01820832</DOCNO>
	<brief_summary>The safety efficacy Caltriol mild proteinuria ( &lt; 1.0g/d ) reduction CKD patient .</brief_summary>
	<brief_title>Oral Calcitriol Reduction Mild Proteinuria Patients With CKD</brief_title>
	<detailed_description>Proteinuria capital sign kidney disease , also marker chronic kidney disease ( CKD ) progression . Emerging evidence patient CKD show vitamin D analog reduce proteinuria albuminuria presence angiotensin-converting enzyme inhibithion . While study report vitamin D receptor activation associate increase serum creatinine reduce estimate glomerular filtration rate . Therefore , investigator plan conduct randomized clinical study evaluate efficacy safety Calcitriol treatment mild proteinuria ( &lt; 1.0g/d ) CKD patient , specific treatment present .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>age 1875 year clinical diagnose and/or biopsyconfirmed primary glomerulonephritis proteinuria 0.151.0 g/d 2 consecutive sample within 4 week despite ACE inhibitor ( ACEI ) angiotensin receptor blocker ( ARB ) treatment least 1 year ACEI/ARB withdrawal drug intolerance ( low blood pressure , cough , hyperkalemia ) least 1 month estimate glomerular filtration rate ( eGFR ) &gt; 60ml/min/1/73m2 corticosteroid immunosuppressive agent withdrawal least 6 month normal blood pressure serum intact parathyroid hormone ( iPTH ) level &gt; 20pg/mL correct serum calcium level &lt; = 2.55 mmol/L serum phosphorus level &lt; = 1.68 mmol/L 24 hour urinary calcium excretion level &lt; = 7.5 mmol receive treatment vitamin D analogue within 6 month willigness give write consent comply study protocol history sensitivity allergy calcitriol vitamin D analogs pregnancy , lactate woman history severe coexist disease , limited , chronic liver disease , myocardial infarction , cerebrovascular accident , malignant hypertension history malignancy history extraskeletal calcification , hyperuricemia , gout , kidney stone , gall stone , bone diseases patient receive drug contains calcium patient receive cimetidine , trimethoprim , drug increase tubular creatinine reabsorption participation trial within 1 month history noncompliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>mild proteinuria</keyword>
	<keyword>calcitriol</keyword>
	<keyword>renal function</keyword>
	<keyword>blood pressure</keyword>
</DOC>